DIABETIC NERVE PAIN WILL AFFECT APPROXIMATELY 5 MILLION AMERICANS IN 2020

Find Out More About this Condition. Capsian Patch, ... can be considered. a specific approved product is QutinzaMore than 34 million Americans – just over 1 in 10 – have diabetes1, and neuropathic pain associated with diabetic peripheral neuropathy of the feet, or more commonly referred to as diabetic nerve pain, is one of its most common complications.2The painful symptoms associated with this nerve damage include numbness, tingling, as well as shooting or stabbing sensations that most often affect the lower extremities.3Itis a progressive and debilitating complication of diabetes that will affect approximately more than 5 million Americans in 20204 and is expected to double by 2030.5Joining us now to discuss neuropathic pain associated with diabetic peripheral neuropathy – or diabetic nerve pain – and this newly approved treatment option is Dr. David Simpson, Professor of Neurology at the Icahn School of Medicine at Mount Sinai in New York City.Key Facts and Figures:• The lack of effective, innovative treatment options has left many patients with a significant unmet medical need.• The condition is more common in patients with type 2 diabetes and increases with age and duration of disease.When you book a window, we’ll provide you with guest bio & suggested questions. The interview is courtesy of Averitas Pharma, Inc.for video and more info, go to http://goodnewsplanet.com/diabetic-nerve-pain-will-affect-approximately-5-million-americans-in-2020/